ELICIT-PLANT
One year after joining the French Tech Agri 20 program, Agri-tech company ELICIT PLANT has joined the circle of the 100 most strategic and innovative French companies for France by 2030, as part of the French Tech 2030 program.
Following a rigorous selection process led by the French General Secretariat for Investment – the body in charge of the France 2030 program – with the help of all French government departments and Bpifrance, ELICIT PLANT, a pioneering company at the forefront of the fight against the impact of climate change on agriculture, and in particular on field crops (corn, wheat, soy and sunflower), has made a striking entrance into the first edition of the French Tech 2030 program.
The initiative aims to provide great public support to one hundred or so innovative companies, in a context of highly aggressive international competition, so as to position them as world leaders by 2030, by providing:
- Financial support, provided by France 2030 operators,
- Extra-financial support measures: export, business opportunities, global economic influence strategy, increased visibility.
This announcement adds to the legitimacy of the track record and international development of ELICIT PLANT, the developer of the first phytosterol-based ecological innovation for the agricultural industry, the only widely available technology scale that allows for significant field crop yield gains in an increasingly critical climatic context.
Several French departements are being affected by drought even before the start of the summer season, leaving public authorities no other option but to impose water restrictions in certain areas. The risk of drought is now accepted as fact in a number of regions. This is cause for concern among scientists, who fear that the summer of 2023 will be even more difficult than 2022.
ELICIT PLANT, the biotech that pioneers phytosterols to help the field crop industry combat water stress
The flagship BEST-a product designed for corn production reduces water consumption by up to 20%, and is in high demand in France, Brazil and Ukraine, with over 100 cooperative customers.
In 2023, the ELICIT PLANT innovation will be distributed to 100 coops and distributors, addressing a total potential of 100,000 corn growers and 10 million hectares of corn in France, Brazil and Ukraine.
ELICIT PLANT has created at the heart of its open-field laboratory based in Moulins-sur-Tardoire a technological platform called EliTerra® that will enable the company to develop new products designed for the culture of wheat and barley in Europe, of sunflower in Ukraine and of soybeans for the Brazilian market. Marketing authorization applications are also underway in the United States.
“We are very proud to join the French Tech 2030 program, Jean-François Déchant, Co-founder and CEO of ELICIT PLANT comments. Our mission is to help the field crop industry everywhere in the world address climate change. The French Tech 2030 project will accelerate our development in France and in the world (Brazil, Ukraine and North America). There is an urgent need to provide innovative solutions to growers, and we are proud to be able to contribute effectively to the necessary agricultural transition with high-performance, reliable products that respect our environment."
About Elicit Plant:
Elicit Plant is an agri-biotech company whose ambition is to become the champion of the ecological transition for agriculture and respond to the global challenges of the impact of climate change on row crops. EliTerra®, Elicit Plant's proprietary technology, is based on the exogenous contribution of phytosterols, a set of molecules of plant origin, which increases the resistance of plants to stress by eliciting their natural defenses. Large-scale field trials - more than 500 trials on 3 continents - have demonstrated that the biosolutions from the Eliterra® Platform are the only ones offering farmers a regular and sufficient return on investment for use on field crops, with an average yield gain of 12%. In 2022, Elicit Plant began marketing its BEST-a product line in France, particularly for corn crops, and has obtained marketing authorizations for Ukraine, Brazil and Europe. For more information: www.elicit-plant.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230620520000/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Curatis discloses Corticorelin as active substance of C-PTBE-0123.5.2025 07:00:00 CEST | Press release
Corticorelin Market Opportunity in Peritumoral Brain Edema (PTBE) expected to exceed USD 1 billion; Strengthens team with Dr. Kirsty Crame and Dr. Timm Trenktrog An epidemiological market study commissioned by Curatis Holding AG (SIX:CURN, “Curatis”) shows that the target patient group is substantially larger than previous estimates. In the US alone, over 150,000 patients suffer from peritumoral brain edema in association with malignant tumors. In previous clinical studies, human corticorelin (C-PTBE-01), demonstrated significant benefits in the treatment of PTBE. “The prospect of developing a potential blockbuster drug with that can contribute significantly to the quality of life of many patients, combined with the potential of maintaining the efficacy of immunotherapies for these patients, is very motivating and exciting,” said Dr. Roland Rutschmann, Curatis CEO. Key statements Corticorelin (hCRH), a 41 amino acid endogenous polypeptide, has demonstrated the ability to positively imp
Merck Showcases Innovation in Advanced Cancers and Rare Tumors at ASCO 202522.5.2025 23:43:00 CEST | Press release
Data from Phase 3 MANEUVER study demonstrating significant improvements in physical function and symptoms in patients with tenosynovial giant cell tumor (TGCT) treated with pimicotinib, to be featured in oral presentationLatest results for potential first-in-class anti-CEACAM5 ADC precemtabart tocentecan (M9140) highlight strong rationale for further development in colorectal cancer (CRC)Not intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced the presentation of new oncology data across more than 12 tumor types at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, May 31 to June 4 in Chicago. The presentations include the Phase 3 MANEUVER data for potentially best-in-class pimicotinib in the treatment of the rare tumor TGCT, as well as data from both company- and investigator-sponsored studies highlighting the company’s focus on advancing differentiated molecules to tackle some of the most challenging cancers.
Cooperation between Topcon Positioning Systems and Amberg Technologies Ltd.22.5.2025 22:17:00 CEST | Press release
Topcon Positioning Systems and Amberg Technologies Ltd. have initiated a close collaboration to enable interoperability between Topcon’s sensor solutions and Amberg Technologies’ software and hardware platforms for rail and tunnel applications. This marks the first step towards offering fully integrated solutions to our shared customers. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250522363239/en/ Luc Le Maire, Senior Vice President, Topcon (left) and Johannes Mueller, CEO, Amberg Technologies. About Topcon Positioning Systems Topcon Positioning Systems is an industry-leading designer, manufacturer and distributor of precision measurement and workflow solutions for the global construction, geospatial and agriculture markets. Topcon Positioning Systems is headquartered in Livermore, California, U.S. (topconpositioning.com, LinkedIn, X, Facebook, Instagram). Its European head office is in Zoetermeer, Netherlands. Topcon Cor
LBT Holdings Ltd. Acquires Gonet Bank & Trust Limited, Introducing Bank of Nassau to Uphold the Finest Traditions of Private Banking22.5.2025 18:29:00 CEST | Press release
LBT Holdings Ltd., in partnership with Gonet SA, is pleased to announce the successful acquisition of Gonet Bank & Trust Limited, a distinguished Bahamas-based private bank formerly owned by Gonet SA. The transaction, which has received full regulatory approval from the Swiss Financial Market Supervisory Authority (FINMA), the Central Bank of The Bahamas (CBOB), and The Securities Commission of The Bahamas (SCB), marks a significant milestone for both organizations. Effective immediately, LBT Holdings Ltd. assumes 100% ownership of Gonet Bank & Trust Limited. As part of this strategic transition, Gonet Bank & Trust Limited will be rebranded as Bank of Nassau 1982 Limited, reflecting its renewed vision and commitment to excellence in private banking and wealth management. This acquisition strengthens the position of all parties in the global financial services sector, enabling expanded service offerings while upholding the highest standards of client-centric banking. Bank of Nassau 1982
Andersen Global indvier medlemsfirmaer i Usbekistan og styrker sin tilstedeværelse i Centralasien22.5.2025 16:34:00 CEST | Pressemeddelelse
Andersen Global styrker sin tilstedeværelse i Centralasien med tilføjelsen af Andersen i Usbekistan, hvilket er en del af den fortsatte udvidelse af organisationens kapaciteter i regionen. Firmaet blev grundlagt i 2009 under navnet Virtus Leo og ledes af den administrerende partner Alisher Zaynutdinov. Siden 2021 har det været samarbejdspartner med Andersen Global. Teamet tilbyder tjenester inden for skatte- og juraforhold inden for en bred vifte af sektorer, herunder overholdelse af skattelovgivningen for selskabser og enkeltpersoner, rådgivning om direkte og indirekte skat, transferpriser, ledelsesrapportering og -analyse, selskabsledelse, konkurrenceret og antitrust, selskabs- og bankret, arbejds- og ansættelsesret, retssager og undersøgelser, fusioner og opkøb, fast ejendom, energi, immaterialret samt familieret. "I kraft af vores professionalisme, gennemsigtighed og evne til at se løsninger samt analytiske tilgang til alle opgaver er vi godt positioneret til at rådgive vores klien
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom